This research sought to determine whether smoking influences affect by means other than withdrawal reduction. Little previous evidence suggests such an effect. We surmised that such an effect would be especially apparent in posttraumatic stress disorder (PTSD) and major depressive disorder (MDD), 2 disorders that are frequently comorbid with smoking and that involve dysregulated affect. Participants were U.S. veterans who were regular smokers (N ϭ 159): 52 with PTSD (58% with comorbid MDD), 51 with MDD, and 56 controls with no psychiatric disorder. During 3 positive and 3 negative mood induction trials (scheduled over 2 sessions), nonwithdrawn participants smoked either a nicotinecontaining cigarette (NICϩ), a nicotine-free cigarette (NICϪ), or held a pen. Positive and negative affect were each measured before and after mood induction. Results showed a significant 2-way interaction of Smoking Condition ϫ Time on negative affect during the negative mood induction (F(6, 576) ϭ 2.41, p ϭ .03) in those with PTSD and controls. In these groups, both NICϩ and NICϪ, relative to pen, produced lower negative affect ratings after the negative mood induction. There was also a 2-way interaction of Smoking Condition ϫ Time on positive affect response to the positive mood induction among those with PTSD and controls (F(6, 564) ϭ 3.17, p ϭ .005) and among MDD and controls (F(6, 564) ϭ 2.27, p ϭ .036). Among all smokers, NICϩ enhanced the magnitude and duration of positive affect more than did NICϪ. Results revealed affect modulation outside the context of withdrawal relief; such effects may motivate smoking among those with psychiatric diagnoses, and among smokers in general.
As smoking prevalence continues to decline in the general population, smoking rates remain intractably high in those with mental health disorders (e.g., Steinberg, Williams, & Li, 2015) . For instance, both posttraumatic stress disorder (PTSD) and major depressive disorder (MDD) are characterized by especially high rates of smoking prevalence, heavy smoking, and low quit rates (Feldner, Babson, & Zvolensky, 2007; Lasser et al., 2000; McClave et al., 2009; Weinberger, Mazure, Morlett, & McKee, 2013) . Tobacco smoking among those with PTSD and with MDD is an important clinical and public health concern because both disorders are fairly prevalent (Breslau, Davis, & Schultz, 2003; Breslau, Johnson, Hiripi, & Kessler, 2001; Kessler et al., 2005) and because smoking contributes to disproportionate morbidity and mortality in these populations (Druss et al., 2011) . To date, the processes that motivate smoking in persons with PTSD and MDD remain poorly understood. The current experiment arises, in part, from the notion that improved understanding of the psychological mechanisms underlying smoking in these populations could inform treatment development and ultimately improve quitting success for smokers with PTSD and MDD.
PTSD and MDD are both associated with severe elevations in negative affect and deficits in positive affect (Beckham et al., 2000; Joormann & Stanton, 2016) . We posited that to the extent that smoking regulates affect, this effect might be especially important for persons with those disorders. It has been proposed that the higher-order affective dimensions (i.e., high negative affect and low positive affect) that span different mental health disorders might broadly underlie the relation between smoking and mental illness (Ameringer & Leventhal, 2010) . This suggests that smoking would produce the same pattern of affect modulation across those with either disorder. Alternatively, if smoking's effects on affect are influenced by factors that are unique to each disorder, then different patterns of affective modulation by nicotine would be observed. To date, the effects of smoking on affective responding captured in real time have not been directly compared for different psychiatric disorders. Thus, the transdiagnostic effects of smoking on affect remain unknown.
The results of the present study were compared with the predictions of two motivational models. One model was the negative reinforcement model, which has received considerable empirical and experimental support (e.g., Baker, Piper, McCarthy, Majeskie, & Fiore, 2004; Eissenberg, 2004; Pang, Khoddam, Guillot, & Leventhal, 2014; Robinson et al., 2011) . This model holds that avoidance and escape from distress powerfully motivates addictive drug use, including smoking (Baker et al., 2004) . For instance, it is clear that nicotine ameliorates withdrawal induced negative affect (e.g., Gloria et al., 2009; Perkins et al., 2008; Perkins & Karelitz, 2015; Perkins, Karelitz, Conklin, Sayette, & Giedgowd, 2010; Shahab, McEwen, & West, 2011; Strong et al., 2011; Zinser, Baker, Sherman, & Cannon, 1992) and that affective distress serves as a powerful prod to smoking lapses and relapse (Baker et al., 2004; Conklin & Perkins, 2005; Shiffman, Paty, Gnys, Kassel, & Hickcox, 1996) . It is less clear, however, that nicotine mitigates stress-induced negative affect or distress (Kassel, Stroud, & Paronis, 2003; Perkins et al., 2010) . Some laboratory studies found that smoking mitigates stressorinduced negative affect (Gilbert, Robinson, Chamberlin, & Spielberger, 1989; Juliano & Brandon, 2002) , but others have not (Conklin & Perkins, 2005; Herbert, Foulds, & Fife-Schaw, 2001; Willner & Jones, 1996) . Thus, the question of whether nicotine reduces stress-induced negative affect remains unresolved (Kassel et al., 2003; Perkins et al., 2010) despite its relevance to theoretical models of addiction (Baker et al., 2004) .
The negative reinforcement model may be especially relevant to PTSD and MDD since both disorders are associated with high levels of negative affect and reactivity to negative stimuli (Beckham et al., 2000; Cook, McFall, Calhoun, & Beckham, 2007; Joormann & Stanton, 2016; Orr, Lasko, Shalev, & Pitman, 1995; Orsillo, Batten, Plumb, Luterek, & Roessner, 2004) . Also, smokers with PTSD and/or current MDD strongly endorse the notion that smoking reduces distress (Beckham et al., 1997; Currie, Hodgins, el-Guebaly, & Campbell, 2001 ). In smokers with PTSD, ad lib smoking tends to be more frequently preceded by anxiety and stress than it is in smokers without the disorder (Beckham et al., 2008) . Further, negative affect likely spurs smoking lapse (Beckham, Calhoun, Dennis, Wilson, & Dedert, 2013) and relapse (Brodbeck, Bachmann, Brown, & Znoj, 2014) , in persons with either PTSD or depression. One experiment showed that nicotinized and denicotinized cigarettes similarly reduce negative affect (although these smoking manipulations were not compared with a neutral stimulus) in both smokers with PTSD and nondiagnosed smokers . Another study found that depression was positively associated with more puffs and longer smoking in response to a sad stimulus (Fucito & Juliano, 2009 ). In summary, there is evidence that negative affect influences smoking in those with PTSD or MDD, but, as with smokers in general, it is unclear whether smoking reduces negative affect by means other than withdrawal relief. Thus, we believed it was vital to examine whether (a) smoking ameliorates stressor-induced negative affect among smokers in general, and, (b) whether this effect is magnified among smokers with either PTSD or MDD.
This experiment also derived hypotheses from the reward enhancement model. This model posits that smoking has the potential to enhance pleasurable responses to rewarding events that smokers encounter in their daily lives. In support of this model, the administration of nicotine to rodents increases their rate of responding for nondrug rewards (e.g., Caggiula et al., 2008; Chaudhri et al., 2006; Donny et al., 2003) . This effect appears to be because of the direct, agonist effects of nicotine as it occurs regardless of prior conditioning contingencies (Chaudhri et al., 2006) . Human research similarly suggests that nicotine increases the value of nondrug rewards as reflected by increased responding for exposure to auditory (music) or visual (video) rewards (Perkins, Karelitz, Jao, & Stratton, 2013) .
The reward enhancement model might be especially relevant in smokers with PTSD and MDD since both disorders are associated with blunted responsivity to environmental rewards (i.e., anhedonia; Hasler, Drevets, Manji, & Charney, 2004; Litz & Gray, 2002) . In addition, anhedonia/low positive affect are positively related to heavier smoking in those with PTSD Joseph et al., 2012) . Among smokers with a history of depression, anhedonia increases risk for relapse, even when accounting for depressive symptoms (Cook, Spring, McChargue, & Doran, 2010) . In one experimental study, history of MDD (relative to no history) enhanced nicotine's effects on positive affect in response to a positive autobiographical memory. However, nicotine's mood regulating effects were not moderated by current MDD (Spring et al., 2008) . Clearly, additional laboratory data are needed to assess the This document is copyrighted by the American Psychological Association or one of its allied publishers.
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magnitude of smoking induced reward enhancement in smokers and whether it differs with diagnostic status. Thus, we examined whether (a) smoking enhances positive affective response to nondrug rewarding stimuli, and (b) whether this effect is magnified among smokers with either PTSD or MDD. An assumption here is that the extent to which smoking enhances the pleasure ratings made with regard to a stimulus indexes both the reward value of the stimulus and the strength of a reward enhancement motive to smoke.
To characterize smoking motivational processes (i.e., negative reinforcement, reward enhancement) among those with PTSD and with MDD, we: (a) exposed participants to personalized negative and positive auditory scripts to manipulate their positive and negative affect; (b) allowed participants to smoke nicotine-containing cigarettes, nicotine-free cigarettes, or handle a neutral object during the affectively valenced scripts; and (c) compared the affective responses of persons with PTSD and with MDD to those with no psychiatric diagnosis. The following strategies were used to enhance the external and internal validity of this research:
Route of Nicotine Administration
Ad libitum cigarette smoking was used as the route of nicotine administration because our goal was to examine the affective impact of smoking as it would occur in nonexperimental contexts. Nonsmoking nicotine delivery strategies, such as nicotine nasal spray, may distort the orosensory and pharmacologic effects of smoking, potentially influencing the affective impact of the experience (Perkins et al., 2008) . Also, smoking was ad libitum because prior research suggests that restricted or controlled puffing may produce attenuated motivational effects (Perkins et al., 2008) .
Nonpharmacologic Control
We attempted to control for the nonpharmacologic (motoric, orosensory) and expectancy effects of smoking by using denicotinized cigarettes and manipulation of a neutral object (a pen).
Nonwithdrawal State
This experiment used smokers who were minimally deprived of nicotine (27 min) to analyze the effects of smoking and affective cues on mood, relatively unaffected by withdrawal relief.
Personally Relevant Affect Manipulations
Finally, we used personally relevant and tailored affect manipulations versus standardized stressors (e.g., unpleasant photographic slides) to manipulate affect. Script-elicited imagery is well validated and reliable across PTSD populations (e.g., Orr, Pitman, Lasko, & Herz, 1993; Pitman, Orr, Forgue, de Jong, & Claiborn, 1987) and tends to produce stronger effects than do generic mood prompts (Pitman et al., 1987) .
Manipulation Timing
In this research, participants smoked (or held a pen in a control condition) during exposure to the affectively valenced scripts. In most prior research, affectively valenced stimuli such as stressors were presented before smoking or nicotine administration (Conklin & Perkins, 2005; Herbert et al., 2001; Willner & Jones, 1996) , or interspersed, with them (Perkins et al., 2010) . We used a concurrent smoking-script exposure strategy for several reasons. First, alcohol's stress dampening effects depend upon alcohol effects early in the stress appraisal process (Sayette, 1993) ; a similar effect might be present for nicotine. Also, concurrent exposure might be externally valid because smokers respond to stress by smoking (Conklin & Perkins, 2005) . Third, prohibiting smoking during stress may produce behavioral withdrawal effects (Baker, Japuntich, Hogle, McCarthy, & Curtin, 2006) . In summary, this research was intended to elucidate the motivational bases of smoking in those with either PTSD or MDD, as well as in smokers in general. We hypothesized that relative to nondiagnosed controls, smokers with either PTSD or MDD would report greater negative affect in response to a stressor, and less positive affect in response to an appetitive stimulus. We also hypothesized that smoking a nicotine-containing cigarette would produce greater affect modulation (negative affect reduction and positive affect enhancement) than would smoking a denicotinized cigarette or holding a neutral stimulus. Further, we believed that nicotine induced affect modulation would be magnified among those with either PTSD or MDD, relative to controls. Finally, we hypothesized that smoking a denicotinized cigarette would produce greater affect modulation than holding a neutral object, and that this effect would be magnified among smokers with either PTSD or MDD.
Method

Participants
Participants were 159 U.S. veterans from southern Wisconsin who were recruited from a VA hospital via fliers. All participants were U.S. veterans (enrolled at a VA hospital) ranging in age from 18 -65 who had smoked at least 10 cigarettes per day for the past year and produced a carbon monoxide (CO) value Ͼ8 ppm. This research was advertised to veterans as a study examining the effect of smoking on mood states. Eligible participants met Diagnostic and Statistical Manual for Mental Disorders-Fourth Edition (DSM-IV) criteria for one of the following categories: PTSD (n ϭ 52), MDD (n ϭ 51), or no current psychiatric disorder (controls) (n ϭ 56). In the PTSD group, 30 (57.7%) met criteria for comorbid MDD, consistent with population based comorbidity estimates (Elhai, Grubaugh, Kashdan, & Frueh, 2008) . Exclusion criteria included current use of nicotine replacement therapy, bupropion or varenicline; current Axis I disorders other than tobacco dependence, MDD, and PTSD. This study was approved by the University of Wisconsin Health Sciences Institutional Review Board.
Screening
After a brief telephone screen, study candidates were scheduled for an in-person screening session that involved CO assessment, a diagnostic interview, and other baseline measures. Those who were eligible and provided consent were scheduled for two experimental sessions for Study 1 and two experimental sessions for Study 2; only results from Study 1 are described in the manuscript. This document is copyrighted by the American Psychological Association or one of its allied publishers.
Experimental Sessions
Participants participated in two, 3.5-hr laboratory sessions (see Figure 1a for Session Overview). During each of the sessions, participants underwent three mood induction trials (positive or negative), with the order to the two types being counterbalanced between participants over the two days of testing.
1 During each of the three negative and three positive mood induction trials, participants either smoked a cigarette containing nicotine (NICϩ), a nicotine-free cigarette (NICϪ), or held a pen, with order of smoking condition counterbalanced among participants across the mood induction trials. On testing days, participants were asked to avoid caffeine for 2 hr before testing to prevent acute stimulating effects of caffeine on mood and were asked to avoid drinking any alcohol on the day of testing. Participants who reported any same-day alcohol consumption or caffeine consumption within the prior 2 hr were rescheduled for a make-up session to occur at least 24 hr later. CO was assessed at the beginning of each session to assure CO value of at least 8 ppm.
At the beginning of each of the three mood induction trials within each session, participants smoked one of their own-brand cigarettes to standardize nicotine exposure and ensure that they were not in withdrawal (see Figure 1a) . Use of the smokers' own cigarette brand permitted variability in cigarette nicotine levels, but was thought to produce a smoking experience that was externally valid for each smoker (Spring et al., 2008) . After smoking their own-brand cigarette, participants first read neutral sentences and were then allowed to read magazines provided by the study (see Figure 1b) . Following the 22-min rest period, participants completed self-report baseline affect measures for 5 min. Participants then underwent the mood induction while smoking an experimental cigarette (either NICϩ or NICϪ) or holding a pen (Minute 0 on Figure 1b timeline: 27 min after finishing own-brand cigarette). We designed the experiment so that the latency between own-brand smoking at the beginning of each trial and the smoking manipulation would be less than 30 min, a time period too brief to produce, on average, significant increases in withdrawal symptoms (Bujarski et al., 2015; Hendricks, Ditre, Drobes, & Brandon, 2006) . Mood was assessed immediately after mood induction (Time 1), and then again at 7 min (Time 2, immediately after smoking NICϩ, NICϪ, or holding a pen) and at 18 min after the start of mood induction (Time 3: see Figure 1b ).
Mood Induction
Mood inductions involved imagining three positive and three negative autobiographical memories (Spring et al., 2008) . During the screening session, participants reported positive and negative memories via a semistructured interview format. Participants rated on 1-5 Likert scales how happy or distressed each positive or negative memory, respectively, made them feel and how vividly they recalled each memory. Research staff assisted participants in selecting memories for the mood induction trials that were rated as Ն4 for both valence (happy or distressed) and vividness (although ratings of ϭ 3 were accepted if more elevated ratings could not be obtained). To increase comparability of the negative memories across diagnostic groups, trauma memories were not used.
2 For the selected negative memories, the average level of distress was 4.58 (SD ϭ .54) and vividness was 4.66 (SD ϭ .46). For the positive memories, the average level of happiness was 4.46 (SD ϭ .41) and vividness was 4.69 (SD ϭ .46).
3
The selected positive and negative memories were recorded and then delivered via a headset during trials. Participants were instructed to close their eyes and remember the memory in detail, while trying intensely to re-experience the happy or sad/distressing feelings of the memory.
Nicotinized/Denicotinized Cigarettes
Nicotinized (containing .6 mg nicotine) and denicotinized cigarettes (containing .05 mg nicotine) that were smoked during the mood induction trials were produced by Quest and matched on tar and carbon monoxide content. Participants were not informed which cigarette they were smoking.
Assessments
Structured Clinical Interviews were conducted by a trained diagnostician to assess MDD, PTSD, and other Axis I Disorders. The Structured Clinical Interview for DSM-IV, nonpatient version (SCID; Spitzer, Williams, Gibbon, & First, 1992 ) was used to assess MDD and other Axis I Disorders that were excluded from the study. The Clinician-Administered PTSD Scale (CAPS; Blake et al., 1990 ) was used to assess PTSD. A total CAPS score Ն50 was required for inclusion in the PTSD group (Weathers, Keane, & Davidson, 2001 ). The diagnostician was supervised by a licensed clinical psychologist.
Smoking Status was assessed via self-report and CO test (via an Ecolyzer, Bedfont). To be included in the study, subjects had to report smoking Ն10 cigarettes daily for at least the past year and have a CO score Ն8.
Positive and Negative Affect was assessed via the Positive and Negative Affect Schedule (PANAS; Watson, Clark, & Tellegen, 1988) . The PANAS is a self-report state mood questionnaire comprising 10 adjectives describing positive mood states and 10 adjectives describing negative mood states that are rated on a 5-point scale.
Dependence. The Fagerström Test for Nicotine Dependence (FTND: Heatherton, Kozlowski, Frecker, & Fagerstrom, 1991) , was used to assess tobacco dependence (␣ ϭ .61).
Analytic Plan
The PTSD, MDD, and control groups were compared on demographic, baseline mood, and smoking variables using analyses of variance (ANOVA) for continuously scaled variables 1 Affective responses to the three positive and three negative mood inductions were stable across trials.
2 Typical negative memories included divorce, death of loved one, job loss; typical positive memories involved the birth of a child/grandchild, marriage, graduations, and special vacations.
3 There were no diagnostic group differences for negative memory ratings of distress or vividness, nor were there differences for positive memory ratings of happiness. However, participants with posttraumatic stress disorder (PTSD) rated positive memories as significantly less vivid (M ϭ 4.47, SD ϭ .61) than controls (M ϭ 4.83, SD ϭ .25; p ϭ .02) and participants with major depressive disorder (MDD) rated the positive mood induction memories as less happy (M ϭ 4.54, SD ϭ .53) than controls (M ϭ 4.79, SD ϭ .22; p ϭ .04). This document is copyrighted by the American Psychological Association or one of its allied publishers.
and chi-square tests for dichotomous variables. We also examined the effects of mood induction (positive, negative) and smoking manipulation (NICϩ, NICϪ, and Pen) order on positive and negative affective outcomes using ANOVA. Mean negative affect was examined across the Pen condition of the positive mood induction trials to evaluate the degree to which participants experienced increases in withdrawal-related affective changes during the experiment independent of the negative mood induction. Repeated measures ANOVAs were used to examine the effect of nicotine condition (NICϩ, NICϪ, and Pen), diagnostic group (PTSD vs. control; MDD vs. control), and Time (Baseline, Time 1, Time 2, and Time 3) on change in mood ratings in response to positive and negative mood scripts. Negative affect was the dependent measure for the negative mood induction analyses and positive affect was the dependent measure for the positive mood induction analyses (see supplemental material figures for positive affective response to the negative mood induction and negative affective response to the positive mood induction). Based on a priori hypotheses we conducted focused comparisons (Rosenthal, Rosnow, & Rubin, 2000; Tabachnick & Fidell, 2007) that contrasted each diagnostic group with the controls; that is, via the following orthogonal a priori contrasts: (a) PTSD versus controls (b) MDD versus controls (Tabachnick & Fidell, 2007) . Thus, both negative affect and positive affect ANOVAs were run for both the PTSD versus control comparison and for the MDD versus control comparison (four models). For the within-subjects condition factor, the following a priori contrasts were used: (a) NICϩ versus NICϪ; (b) NICϩ versus Pen; (c) NICϪ versus Pen. For the time factor, orthogonal polynomial contrasts were tested to characterize the temporal pattern of mood responses in terms of their linear and quadratic trend components, with the former indicating linear trend (slope) from Baseline values forward and the latter indicating effects captured by time-squared. Finally, we conducted an exploratory ANOVA that contrasted the MDD and PTSD groups. The Benjamini-Hochberg procedure was used to control experimentwise error in these exploratory analyses (Benjamini & Hochberg, 1995; Keselman, Cribbie, & Holland, 2002) .
With respect to the hypothesized effects, a significant twoway interaction between diagnostic group and time would indicate that diagnostic group affected the temporal pattern of positive and negative affective response to the mood inductions. A significant two-way interaction between smoking condition and time would indicate that the smoking manipulation (NICϩ, NICϪ, or Pen) affected the temporal pattern of affective responses to the mood inductions. A significant three-way interaction among diagnostic group, smoking condition, and time would indicate that the temporal pattern of affective response differed significantly as a function of diagnostic group (PTSD, MDD, and controls) and smoking condition. Analyses were conducted using SPSS (IBM Corporation, 2013) . We report p 2 for effects size with confidence intervals (CIs) computed via SPSS scripts (Smithson, 2003) .
Results
Preliminary Analyses
Group differences between PTSD and controls were found for gender and dependence (see Table 1 ). Analyses with and without covariates produced the same pattern of results (covariates were gender, tobacco dependence, mood induction and nicotine condition order, or MDD-PTSD comorbidity); thus, unadjusted models are presented below.
Missing Data
In total, four participants initially enrolled in the study but did not attend any sessions. These participants were, therefore, excluded from analysis. For the negative mood inductions, 153 (96%) completed all three mood inductions trials, 3 (2%) completed two trials, and 3 (2%) completed 1 trial. For the positive mood inductions, 148 (94%) completed three trials, 6 (4%) com- This document is copyrighted by the American Psychological Association or one of its allied publishers.
pleted two trials, and 4 (3%) completed one experimental trial.
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There were no group differences in missing data. All available data were used in the analyses.
Withdrawal Check
Mean negative affect was examined during the positive mood induction trials to evaluate whether participants experienced increases in withdrawal-related negative affect over the course of a trial independent of negative mood induction. We assumed that if withdrawal were increasing over the course of the trial we would see evidence of steadily increasing negative affect. We examined negative affect during the Pen condition because we wished to avoid smoking or smoking cue effects on withdrawal. Mean negative affect was stable across the trial (B ϭ 14.48 [6.57]; T1 ϭ 14.15 [6.16]; T2 ϭ 14.73 [6.65]; T3 ϭ 14.46 [6.32]) and was highly similar to negative affect assessed during the screening session, which occurred when smokers had been smoking ad lib (14.43 [6.57] ). Thus, these data show no evidence that negative affect increased over the course of a trial or that it was greater than when participants had been smoking ad libitum.
Negative Mood Induction Outcomes
Mean negative affective responses to the negative mood induction for the diagnostic groups are presented in Table 2 . In the PTSD model (PTSD vs. controls), there was a main effect of PTSD on negative affect (F(1, 98) ϭ 38.24, p ϭ .00), suggesting that those with PTSD reported higher levels of negative affect, averaged across time, relative to controls.
There was also a significant PTSD ϫ Time effect (F(3, 576) ϭ 9.10, p ϭ .00; p 2 ϭ .045, 90% CI [.019, .072]) for negative affective responses to the negative mood induction with significant linear (F(1, 96) Figure 2 , relative to controls, those with PTSD experienced a greater rise in negative affect in response to the stressor and showed reduced affective recovery (i.e., less of a decrease in negative mood) after the stressor. There was also a significant Smoking Condition ϫ Time effect (F(6, 576) Figure 3 , the NICϩ and NICϪ conditions produced lower negative affect ratings across T1-T3 than did the Pen condition for controls and those with PTSD (also see Table 2 ). 
Positive Mood Induction Outcomes
Mean positive affective responses to the positive mood induction for the diagnostic groups are presented in Table 2 . In the PTSD model, there was no main effect of PTSD on positive affect (p ϭ .112). However, there was a significant two-way interaction of Smoking Condition ϫ Time on positive affect response to the positive mood induction (F(6, 564) Figure 5 , NICϩ produced greater increases in positive affect than did the Pen condition moving from Baseline across the subsequent assessment time points (T1-T3). 4 One participant participated in only negative mood induction trials and did not complete any positive mood induction trials. Thus, there was one less participant included in the positive mood induction analyses. 5 The negative mood response in those with posttraumatic stress disorder (PTSD) as a sole diagnosis was highly similar to the mood response in those with PTSD ϩ MDD (major depressive disorder; see supplemental material). Figure 6 , the NICϩ condition had a steeper rise from Baseline to T1 relative to the NICϪ condition.
Exploratory Analyses
Exploratory negative mood induction outcomes. Exploratory analyses directly contrasted the PTSD group with the MDD group. 6 Negative affective response to the negative mood induction showed a significant three-way interaction of Diagnostic Group (PTSD vs ). This appears to be due, in part, to Pen's producing an exaggerated quadratic trend relative to NICϩ and NICϪ in those with PTSD, but a relatively diminished quadratic pattern (relative to NICϩ and NICϪ) in those with MDD (see Figure 7a and 7b). Whereas Pen exposure tended to produce an elevated negative affective response across T1-T3 in those with PTSD, it was associated with diminished negative affect relative to NICϩ and NICϪ in those with MDD (see Figure 7a and 7b).
Exploratory positive mood induction outcomes.
There were no significant interactions involving diagnostic group (PTSD vs. MDD) for positive affect.
Discussion
Results showed that the PTSD and MDD groups reported greater negative affect in response to the negative mood induction than did the controls. Results also showed a significant Smoking Condition ϫ Time effect on negative affect in those with PTSD and in controls. Specifically, both NICϩ and NICϪ, relative to Pen, blunted the negative affective response to the stressor and enhanced affective recovery. Thus, both for those with PTSD and for nondiagnosed controls, smoking a cigarette with or without nicotine mitigated the negative affect response to the stressor when the smoker was in a nonwithdrawn state. In contrast to these findings, the NICϩ and NICϪ conditions produced higher negative affect ratings across time in the MDD group; significantly higher than the ratings produced by the PTSD group. No diagnostic group differences were observed with regard to positive affective response to the positive mood induction. However, there was a smoking condition x time effect on positive affective response to the positive mood induction in PTSD versus controls and in MDD versus controls. Among all smokers, NICϩ enhanced experimentally induced positive affect and maintained it relative to NICϪ. NICϩ also elevated positive affect over time relative to the Pen condition in both the PTSD group and controls. This suggests that among those with mental illness (PTSD, MDD) as well as in nondiagnosed controls, smoking a nicotine-containing cigarette 6 We report only effects that involved the diagnostic group effect (posttraumatic stress disorder [PTSD] vs. major depressive disorder [MDD] ) in these analyses to avoid repeating analyses of nicotine condition effects per se. Note. NA ϭ negative affect measured during the negative mood induction trial; PA ϭ positive affect measured during the positive mood induction trial; NICϩ ϭ nicotine-containing cigarettes; NICϪ ϭ denicotinized cigarettes; PTSD ϭ posttraumatic stress disorder; MDD ϭ major depressive disorder.
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enhanced the effects of positive mood induction in nonwithdrawn smokers.
Negative Reinforcement Hypothesis
Mixed evidence for the effects of smoking on stressor-induced negative affect (Conklin & Perkins, 2005; Gilbert et al., 1989; Herbert et al., 2001; Juliano & Brandon, 2002; Willner & Jones, 1996) has led some to posit that smoking might relieve negative affect primarily or only under withdrawal conditions (Parrott & Kaye, 1999; Schachter, 1978) compare (Baker et al., 2004) . The fact that smokers in this research were minimally deprived of nicotine (Ͻ30 min) suggests that withdrawal relief was not a significant influence on smoking's effects on stress related negative affect (Hendricks et al., 2006) . Several factors might contribute to the prior inconsistent findings regarding the acute effects of smoking on stressor-induced distress. For instance, previous research typically examined the effects of smoking after exposure to a stressor (e.g., Conklin & Perkins, 2005; Herbert et al., 2001; Willner & Jones, 1996) ; this study required participants to smoke during the stressor. Smoking early in the course of stress induction might allow smoking to influence stressor appraisal; a stressor might be construed as less aversive when an effective coping response (i.e., smoking) is present (Lazarus & Folkman, 1984) . Moreover, the prevention of smoking until after exposure to the stressor may have exacerbated the stressor effects because of the inability to practice a highly mapped coping response (Curtin, Figure 3 . This figure depicts the negative affect response to negative mood induction averaged across those with posttraumatic stress disorder (PTSD; n ϭ 52) and controls (n ϭ 56). NICϩ indicates nicotinized cigarette and NICϪ indicates denicotinized cigarette. This document is copyrighted by the American Psychological Association or one of its allied publishers.
McCarthy, Piper, & Baker, 2006) . Finally, the use of autobiographic scripts, as opposed to the standardized stressors used in most smoking research (Conklin & Perkins, 2005; Herbert et al., 2001; Willner & Jones, 1996) , may have produced a more intense or meaningful affective experience (Pitman et al., 1987) , potentially creating greater opportunity for negative reinforcement. Both NICϩ and NICϪ relative to the Pen condition resulted in alleviation of negative affect in smokers with PTSD and in controls, and did so in the absence of significant tobacco withdrawal (cf. Beckham et al., 2007; Donny, Houtsmuller, & Stitzer, 2007; Perkins et al., 2008; Perkins et al., 2010) . Further, the equivalence of the effects of NICϩ and NICϪ suggests that it was produced, at least in part, through associative processes. The greater negative affect suppression by NICϪ relative to the Pen condition could be because of any of multiple candidate mechanisms; for example, the execution of the motor elements of smoking, the orosensory elements (Perkins et al., 2008) , attentional effects, expectancy effects, conditioned incentive effects, and conditioned reinforcement. The NICϩ versus Pen condition differences may reflect the effects of the same mechanism(s). We think that the effects of NICϩ and NICϪ on stress induced negative affect may reflect a combination of processes, but posit that conditioned reinforcement occurring via cues associated with the iterative self-administration ritual is a leading candidate. This is supported by a wealth of evidence of the acquisition of strong conditioned reinforcement effects using addictive drug unconditioned stimuli (UCSs; Everitt & Robbins, 2005; Taylor & Robbins, 1984) . Further, the instatement of associative drug motivational effects might be enhanced by stressors and negative affect (Bossert, Marchant, Calu, & Shaham, 2013) . Also, Perkins and his colleagues have shown that the orosensory cues produced by smoking elicit significant suppression of stressrelated negative affect (in withdrawn smokers), even when the smokers knew that smoking would deliver no nicotine. This accords with considerable evidence that interoceptive cues of drug This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
action may be powerful elicitors of drug motivational processes (Baker et al., 2004) . In other words, the effects of denicotinized cigarettes on negative affect may depend strongly on the experience of smoking-related sensory cues (vs. general expectations of nicotine effects). This account, of course, suggests that the effects of denicotinized cigarettes on stressor related negative affect reflect the residue of prior unconditioned effects of nicotine on stress reactivity. It is also possible that the conditioned effects of smoking observed in this study reflect smoking's prior withdrawalreducing effects; that is, such conditioned effects may have arisen from learning where the unconditioned response was withdrawal reduction, not stress reduction. Finally, it is important to note though, that while the effects of NICϩ and NICϪ on stressor induced distress may reflect the history of nicotine's pharmacologic actions, nicotine's contemporaneous, acute pharmacologic actions appeared to have exerted little additional effect on negative affect in this study.
Reward Enhancement Hypothesis
With regard to the reward enhancement hypothesis, we found that for all diagnostic Groups NICϩ enhanced experimentally induced positive affect and maintained it relative to NICϪ. NICϩ also elevated positive affect over time relative to Pen exposure in the PTSD group and in controls. These findings are consistent with research showing that nicotine can enhance the rewarding properties of nonpharmacologic stimuli (Cook, Spring, & McChargue, 2007; Perkins & Karelitz, 2014) . Similar to the current experiment, Perkins and his colleagues (e.g., Perkins & Karelitz, 2014) found that smoking nicotine-containing cigarettes, versus denicotinized cigarettes, enhanced the rewarding effects of appetitive stimuli. However, it is important to recognize key differences between the current experiment and the Perkin's research. First, the current experiment did not measure the effects of smoking on conditioned responding (i.e., on its ability to modulate reinforcement) as did This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
the Perkin's research. Thus, we are inferring that the same processes that cause nicotine's modulation of reinforcement value also affected subjective ratings of reward value. Second, Perkin's research involved withdrawn smokers. Perkins and colleagues argued that withdrawal relief was unlikely to have affected their results (e.g., results with dependent and nondependent smokers were similar; . Through the use of nonwithdrawn smokers, the current results support that assertion.
Further, the current research shows that across all diagnostic groups, smoking enhanced the pleasure induced by imaginal reexperiencing, rather than by an external, sensory stimulus per se (vs. . This considerably broadens the range of experiences whose affective consequences might be modulated by nicotine. Because this effect occurred regardless of withdrawal status , and in response to imaginal processing, it may be perpetually available via smoking.
Effects of Diagnostic Status
Smokers with PTSD and MDD reported greater negative affect in response to stressors than did the controls. Smokers with these diagnoses, therefore, might have greater opportunity for negative reinforcement from smoking given the severity of their distress. However, the effects of smoking on affect were fairly similar when each diagnostic group was compared with the controls. Even though the pattern of affect modulation by smoking was similar between the diagnostic groups and the controls, it could be that the greater affective response magnitudes in those with PTSD and MDD render negative reinforcement motives more appealing in those groups. It is also possible that diagnostic group differences in affect modulation via cigarette smoking might be more apparent in the presence of tobacco withdrawal. Nicotine effectively mitigates withdrawal-related affective distress (e.g., Baker et al., 2004; Gloria et al., 2009) , which is especially severe in smokers with PTSD and MDD (Dedert et al., 2012; Weinberger, Desai, & McKee, 2010) .
One notable diagnostic difference found in this research was that only among those with MDD did smoking NICϩ and NICϪ cigarettes magnify negative affective responding to the stressor. In contrast, smoking suppressed affective reactions to the stressor in both the PTSD and control groups. It is unclear why smoking might have uniquely inflated distress among smokers with MDD. One possibility is that smoking exerts some of its effects by channeling attentional resources (Kassel, 1997) and this has paradoxical effects in the depressed. Kassel's attention allocation model posits that smoking reduces attentional resources so that attention is fixed on current activities or salient stimuli (e.g., smoking), and is less likely to be diverted to intrusive, negative thoughts; presumably avoidance of such thoughts should reduce negative affect. Those with MDD, however, attend to selfreferential negative cognitions preferentially when distractors are present (Nolen-Hoeksema, 1991) . Thus, among those with MDD, smoking might channel attentional resources to the negative memories that are elicited by stressors, and thus magnify the resulting distress (Richmond, Spring, Sommerfeld, & McChargue, 2001) . In any event, the current results suggest that smokers with MDD only may smoke for reasons other than stress relief; for example, reward enhancement. It is also the case that such smokers may merely believe that smoking reduces stress effects because it so effectively reduces withdrawal-related distress.
It is important to note that MDD comorbidity did not appear to meaningfully influence affective reactions of participants with PTSD; that is, PTSD participants performed similarly regardless of MDD status (see supplemental material Figures 4 and 5) . Although comorbidity between PTSD and MDD is extremely common (Ginzburg, Ein-Dor, & Solomon, 2010) , possibly because of the overlap in symptoms across the two disorders (i.e., numbing/dysphoria; Gootzeit & Markon, 2011; Elhai et al., 2015) , we believe that it was the anxiety dimension of PTSD that led to the observed smoking related suppression of negative affect in this experiment. PTSD manifests with strong anxiety related symptoms that are associated with its re-experiencing, hyperarousal, and avoidance dimensions (Byllesby, Durham, Forbes, Armour, & Elhai, 2016; Wang et al., 2011) . Further, research shows that persons with PTSD show especially heightened anxiety in response to stressors and smoking appears to reduce such distress (Beckham et al., 2005 . We believe that smoking may reduce heightened anxiety among persons with PTSD either directly (Hogle, Kaye, & Curtin, 2010) , or via its effects on attentional processing or by mitigating sensorimotor gating deficits (Baschnagel & Hawk, 2008; Calhoun et al., 2011; Vrana et al., 2013) . Some research fails to show that smoking reduces acoustically elicited startle in smokers with PTSD, casting doubt on the notion that smoking exerts anxiolytic effects. However, those results may be challenged on the bases of the timing of the smoking experience in those studies and the fact that the startle paradigm may have primarily activated fear and not anxiety (Calhoun et al., 2011; Vrana et al., 2013) , with the latter likely being more sensitive to smoking effects (Hogle et al., 2010; Jonkman et al., 2008) . In short, we believe that smokers with PTSD are likely to show especially strong anxiety reactions to stressful stimuli, and that nicotine can quell such reactions (Beckham et al., 2005 . It is also important to note that anxiety disorder diagnosis was exclusionary for the MDD condition, reducing the likelihood that heightened anxiety would affect responding of those with MDD.
Treatment Implications
If the effects of smoking on negative affect reflect conditioned reinforcement, then interventions aimed at smoking cue extinction or avoidance strategies might be helpful. Such strategies might focus on exposure to orosensory cues contingent with smoking (e.g., via extended use of denicotinized cigarettes) or even strategies that imaginally induce distress. Our results also underscore the importance of targeting reward reactivity after quitting. If smokers strategically use cigarettes to enhance pleasure in response to nondrug rewards, then quitting could lead to a decrement in the experience of such reward (i.e., anhedonia). Indeed, we have found that quitting smoking leads to anhedonia, and that this loss in postcessation pleasure is a significant barrier to quitting (Cook et al., 2015) . Helping smokers prepare for withdrawal-related anhedonia by encouraging their pursuit of alternative sources of nonsmoking reinforcement might buffer the loss in reward functioning that follows quitting. This document is copyrighted by the American Psychological Association or one of its allied publishers.
Limitations
To enhance both the study's ecological validity and the effects of smoking (Perkins et al., 2008) , participants smoked nicotinized and denicotinized cigarettes ad lib, rather than using a controlled form of nicotine administration. Thus, we relinquished control over the handling and dosing of the cigarettes as well as the ability to detect group differences in smoking patterns. Although such variability likely affected the effects of the smoking experience, it better characterizes participants' smoking as it occurs in nonexperimental contexts. The smoking of three own-brand cigarettes over the course of each session could be viewed as both a strength and a limitation. It is a strength in that it virtually ensures that participants did not experience significant withdrawal during the study; it is a weakness in that the amount of smoking may have blunted affective reinforcement because of mild, undetected aversive effects (this may have been mitigated because smoking was ad libitum). In addition, smoking own-brand cigarettes may have reduced the smoking and nicotine yield of the experimental cigarettes, potentially reducing affective response to them. However, it is important to note that the significant effects of the nicotine containing cigarettes on positive affect suggests that they still possessed the capacity to produce meaningful affective impact. Also, participants did not rate the subjective experience of smoking their own-brand versus the experimental cigarettes; thus, perceived cigarette strength or other qualities could not be compared. Although evidence suggests that participants were minimally deprived of nicotine, the assessment of withdrawal was limited by the absence of a measure of craving. In addition, withdrawal may have been associatively elicited by external or internal cues. We also could not determine the exact processes through which NICϩ and NICϪ cigarettes produced affect modulation. For instance, we do not know if the effects of smoking on reactions to the imaginal scripts were caused by affective modulation per se, or instead because smoking directly affected the ability to access and focus on the relevant imaginal material. In addition, because this veteran sample included primarily men, results may not generalize to women who smoke. Further, no neutral scripts were used in this study (because of concerns regarding experimental burden); thus, we can determine the magnitude of affective responses relative to a baseline, but not relative to a neutral condition. Finally, although positive and negative memories were matched on dimensions of vividness and valence, they were not matched on arousal.
Conclusions
This research may shed light on the motivational bases of smoking in those with and without comorbid psychopathology. First, there was evidence that smoking reduced negative affective response to a stressor in nonwithdrawn smokers. Specifically, smoking either nicotine-containing or denicotinized cigarettes (relative to holding a pen) mitigated negative affective responses to a stressor among smokers with PTSD and among nondiagnosed controls but not for those with MDD. Because denicotinized cigarettes produced this effect, it is likely that the effect is primarily associative in nature. While the mechanism is unknown, this finding is significant since much prior research has failed to find that smoking alleviates stress induced negative affect in nonwithdrawn smokers. Second, smoking a nicotine-containing cigarette (relative to smoking a denicotinized cigarette or holding a Pen) enhanced positive affective ratings of an appetitive stimulus. Third, diagnostic status appeared to affect stress reactivity. Thus, relative to nondiagnosed controls, smokers with comorbid PTSD and MDD reported greater affective distress to the stressor; such heightened stress reactivity could certainly affect the strength of smoking motivation. In addition, only among smokers with MDD did smoking exacerbate stress induced distress relative to a neutral control condition. Such findings encourage further research on mechanisms that may account for the heightened persistence and prevalence of smoking among those with PTSD and MDD. In addition, more research is needed to elucidate the nature of the smoking related conditioned stimuli that elicit associative effects on affective responding to stressors.
